Hwealth Pharmaceutical

Hwealth Pharmaceutical appears to be the English-facing brand associated with Beijing Huashitianfu Biomedical Technology, a China-based biopharmaceutical company. The company is focused on oncology and is best known for K-001, a biologic peptidoglycan complex of spirulina that has been studied in pancreatic cancer and is also associated with development activity in hepatocellular carcinoma and gastric cancer. Publicly available evidence indicates the company has operated as a private, active entity in China and has registered the HWEALTH PHARMA trademark. The available footprint suggests a narrowly focused clinical-stage company rather than a broad commercial pharmaceutical business, with limited publicly disclosed pipeline and corporate information.